Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Jun;8(6):330-9.
doi: 10.1038/nrgastro.2011.59. Epub 2011 Apr 19.

Treatment of refractory and recurrent Clostridium difficile infection

Christina M Surawicz  1 , Jacob Alexander
Affiliations
Review

Treatment of refractory and recurrent Clostridium difficile infection

Christina M Surawicz et al. Nat Rev Gastroenterol Hepatol. 2011 Jun.

Abstract

The incidence of Clostridium difficile infection (CDI) has increased since 2000, with greater numbers of severe cases reported, in part due to the emergence of a hypervirulent strain. Initial therapy with metronidazole is still recommended for mild to moderate CDI, but vancomycin is recommended for first-line therapy of severe CDI. Colectomy could be life-saving for some patients with severe disease that does not respond to maximal medical therapy. Recurrent CDI is a challenge to treat; no single effective therapy currently exists. Treatments include antibiotics, adjunct probiotics, fecal microbiota transplant and immune approaches. This Review discusses the various therapeutic approaches used for the treatment of refractory and recurrent CDI.

PubMed Disclaimer

References

    1. Anaerobe. 2009 Dec;15(6):290-1 - PubMed
    1. Gastroenterology. 2005 Mar;128(3):764-70 - PubMed
    1. J Infect Dis. 2004 May 1;189(9):1585-9 - PubMed
    1. Clin Infect Dis. 2002 Sep 15;35(6):690-6 - PubMed
    1. Nat Clin Pract Gastroenterol Hepatol. 2008 Jan;5(1):40-8 - PubMed